Home  >  News
you can get e-magazine links on WhatsApp. Click here
Marketing + Font Resize -

Avinger expands international presence with first commercial launch of Lumivascular products in Chile

Redwood City, California
Wednesday, June 22, 2022, 17:00 Hrs  [IST]

Avinger, Inc., a commercial-stage medical device company, announced the expansion of its international presence with the commercial launch of its Lumivascular products in Chile. Avinger's new Lightbox 3 imaging console will be used exclusively to support the launch of the Lumivascular platform in Chile.

To support the entry into this new international market, Avinger has signed an exclusive distribution agreement with Importadora y Distribuidora Arquimed Ltda for the sale and marketing of Avinger's proprietary Lightbox 3 imaging console and image-guided Pantheris atherectomy and Tigereye CTO-crossing catheters in Chile. Arquimed is a leading distributor in the medical field in Chile with more than 80 years of successful operating history and approximately 360 employees throughout the country.

"We are excited to expand our global customer base with the addition of Chile as a new market opportunity for Avinger's best-in-class image-guided devices, powered by our new Lightbox 3 imaging console," said Jeff Soinski, Avinger's president and CEO. "The introduction of Lightbox 3, with its enhanced imaging, streamlined user interface, and dramatically reduced size and weight, has the potential to fundamentally change how effectively and efficiently we can expand into new geographies with new customers. We look forward to partnering with Arquimed as they bring our limb and life-saving technologies to their healthcare customers in Chile and look forward to exploring additional international expansion opportunities for our proprietary technologies as the year progresses."

Avinger's Lumivascular technology incorporates an onboard image-guidance system to allow physicians, for the first time ever, to see inside the artery during an atherectomy or CTO-crossing procedure by using an imaging modality called optical coherence tomography, or OCT. During the procedure, high-resolution intravascular OCT images are displayed on Avinger's Lightbox console in real-time to guide therapy. Physicians performing therapeutic procedures with other devices must rely solely on X-ray images and tactile feedback to guide their interventions while treating complicated arterial disease. With the Lumivascular approach, physicians can more accurately navigate their devices and treat PAD lesions to deliver safe and effective outcomes, without exposing healthcare workers and patients to the negative effects of ionizing radiation.

Avinger is a commercial-stage medical device company that designs and develops the first and only image-guided, catheter-based system for the diagnosis and treatment of patients with peripheral artery disease (PAD).


* Name :     
* Email :    
  Website :  
Apollo Clinical Research
Copyright © 2016 Saffron Media Pvt. Ltd |